, Les entrepreneurs qui ont fait faillite devraient avoir une seconde chance, FASEB Journal en, 2013.

. Référence,

A. T. Berg, S. F. Berkovic, M. J. Brodie, J. Buchhalter, J. H. Cross et al., Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009, Epilepsia, vol.51, issue.4, pp.676-685, 2010.

Y. Bozzi and M. Caleo, Epilepsy, Seizures, and Inflammation: Role of the C-C Motif Ligand 2 Chemokine, DNA and Cell Biology, vol.35, issue.6, pp.257-260, 2016.

B. D. Clarkson, R. G. Lafrance?corey, R. J. Kahoud, R. Farias?moeller, E. T. Payne et al., Functional deficiency in endogenous interleukin?1 receptor antagonist in patients with febrile infection?related epilepsy syndrome, Annals of Neurology, vol.85, issue.4, pp.526-537, 2019.

V. Crépel and C. Mulle, Physiopathology of kainate receptors in epilepsy, Current Opinion in Pharmacology, vol.20, pp.83-88, 2015.

E. Cristante, S. Mcarthur, C. Mauro, E. Maggioli, I. A. Romero et al., Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications, Proceedings of the National Academy of Sciences, vol.110, issue.3, pp.832-841, 2012.

D. Davalos, J. Grutzendler, G. Yang, J. V. Kim, Y. Zuo et al., ATP mediates rapid microglial response to local brain injury in vivo, Nature Neuroscience, vol.8, issue.6, pp.752-758, 2005.

A. Depaulis and S. Hamelin, Animal models for mesiotemporal lobe epilepsy: The end of a misunderstanding?, Revue Neurologique, vol.171, issue.3, pp.217-226, 2015.

A. D. Desena, T. Do, and G. S. Schulert, Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade, Journal of Neuroinflammation, vol.15, issue.1, p.38, 2018.

R. Garbelli, C. Munari, S. De-biasi, L. Vitellaro-zuccarello, C. Galli et al., Taylor's Cortical Dysplasia: A Confocal and Ultrastructural Immunohistochemical Study, Brain Pathology, vol.9, issue.3, pp.445-461, 1999.

M. Ghaffarpour, H. A. Ghelichnia, M. H. Harrichian, M. A. Ghabaee, M. M. Saber-tehrani et al., Strategies of Starting and Stopping Antiepileptic Drugs in Patients With Seizure or Epilepsy; a Comprehensive Review, Archives of Neuroscience, vol.2, issue.1, pp.157-165, 2014.

R. Gussenhoven, L. Klein, D. Ophelders, D. Habets, B. Giebel et al., Annexin A1 as Neuroprotective Determinant for Blood-Brain Barrier Integrity in Neonatal Hypoxic-Ischemic Encephalopathy, Journal of Clinical Medicine, vol.8, issue.2, p.137, 2019.

M. P. Jacobs, G. G. Leblanc, A. Brooks-kayal, F. E. Jensen, D. H. Lowenstein et al., Curing epilepsy: Progress and future directions, Epilepsy & Behavior, vol.14, issue.3, pp.438-445, 2009.

W. Klement, M. Blaquiere, E. Zub, F. Debock, F. Boux et al., A pericyte?glia scarring develops at the leaky capillaries in the hippocampus during seizure activity, Epilepsia, vol.60, issue.7, pp.1399-1411, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02335992

W. Klement, R. Garbelli, E. Zub, L. Rossini, L. Tassi et al., Seizure progression and inflammatory mediators promote pericytosis and pericyte-microglia clustering at the cerebrovasculature, Neurobiology of Disease, vol.113, pp.70-81, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02071090

D. H. Kusters, M. L. Chatrou, B. A. Willems, M. De-saint-hubert, M. Bauwens et al., Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR-/- Mice on Western Type Diet, PLOS ONE, vol.10, issue.6, p.e0130484, 2015.

W. Löscher, Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs, Neurochemical Research, vol.42, issue.7, pp.1873-1888, 2017.

N. Marchi, T. Granata, E. Freri, E. Ciusani, F. Ragona et al., Efficacy of Anti-Inflammatory Therapy in a Model of Acute Seizures and in a Population of Pediatric Drug Resistant Epileptics, PLoS ONE, vol.6, issue.3, p.e18200, 2011.

N. Marchi, T. Granata, and D. Janigro, Inflammatory pathways of seizure disorders, Trends in Neurosciences, vol.37, issue.2, pp.55-65, 2014.

S. L. Moshé, E. Perucca, P. Ryvlin, and T. Tomson, Epilepsy: new advances, The Lancet, vol.385, issue.9971, pp.884-898, 2015.

V. Nadler and J. , Kainic acid as a tool for the study of temporal lobe epilepsy, Life Sciences, vol.29, issue.20, pp.2031-2042, 1981.

J. W. Olney, V. Rhee, and O. L. Ho, Kainic acid: a powerful neurotoxic analogue of glutamate, Brain Research, vol.77, issue.3, pp.507-512, 1974.

J. Park, S. H. Baik, S. Han, H. J. Cho, H. Choi et al., Annexin A1 restores A?1-42-induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway, Aging Cell, vol.16, issue.1, pp.149-161, 2016.

J. Park, S. H. Baik, S. Han, H. J. Cho, H. Choi et al., Annexin A1 restores A?1-42-induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway, Aging Cell, vol.16, issue.1, pp.149-161, 2016.

G. Paxinos and C. Watson, WITHDRAWN: Acknowledgements, The Rat Brain in Stereotaxic Coordinates, p.vii, 1982.

M. Perretti and F. D'acquisto, Annexin A1 and glucocorticoids as effectors of the resolution of inflammation, Nature Reviews Immunology, vol.9, issue.1, pp.62-70, 2009.

M. Perretti, X. Leroy, E. J. Bland, and T. Montero-melendez, Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation, Trends in Pharmacological Sciences, vol.36, issue.11, pp.737-755, 2015.

H. M. Peshavariya, C. J. Taylor, C. Goh, G. S. Liu, F. Jiang et al., Annexin Peptide Ac2-26 Suppresses TNF?-Induced Inflammatory Responses via Inhibition of Rac1-Dependent NADPH Oxidase in Human Endothelial Cells, PLoS ONE, vol.8, issue.4, p.e60790, 2013.

H. M. Peshavariya, C. J. Taylor, C. Goh, G. Liu, F. Jiang et al., Annexin Peptide Ac2-26 Suppresses TNF?-Induced Inflammatory Responses via Inhibition of Rac1-Dependent NADPH Oxidase in Human Endothelial Cells, PLoS ONE, vol.8, issue.4, p.e60790, 2013.

G. S. Purvis, F. Chiazza, J. Chen, R. Azevedo-loiola, L. Martin et al., Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes, Diabetologia, vol.61, issue.2, pp.482-495, 2017.

G. S. Purvis, E. Solito, and C. Thiemermann, Annexin-A1: Therapeutic Potential in Microvascular Disease, Frontiers in Immunology, vol.10, p.10, 2019.

T. Ravizza, B. Gagliardi, F. Noé, K. Boer, E. Aronica et al., Innate and adaptive immunity during epileptogenesis and spontaneous seizures: Evidence from experimental models and human temporal lobe epilepsy, Neurobiology of Disease, vol.29, issue.1, pp.142-160, 2008.

V. Riban, V. Bouilleret, B. T. Pham-lê, J. Fritschy, C. Marescaux et al., Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy, Neuroscience, vol.112, issue.1, pp.101-111, 2002.

M. Sato, R. J. Racine, and D. C. Mcintyre, Kindling: basic mechanisms and clinical validity, Electroencephalography and Clinical Neurophysiology, vol.76, issue.5, pp.459-472, 1990.

S. M. Stamatovic, P. Shakui, R. F. Keep, B. B. Moore, S. L. Kunkel et al., Monocyte Chemoattractant Protein-1 Regulation of Blood?Brain Barrier Permeability, Journal of Cerebral Blood Flow & Metabolism, vol.25, issue.5, pp.593-606, 2005.

D. J. Thurman, E. Beghi, C. E. Begley, A. T. Berg, J. R. Buchhalter et al., Standards for epidemiologic studies and surveillance of epilepsy, Epilepsia, vol.52, pp.2-26, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00678734

P. G. Trentin, T. P. Ferreira, A. C. Arantes, B. T. Ciambarella, R. S. Cordeiro et al., Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice, British Journal of Pharmacology, vol.172, issue.12, pp.3058-3071, 2015.

F. Twele, K. Töllner, C. Brandt, and W. Löscher, Significant effects of sex, strain, and anesthesia in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy, Epilepsy & Behavior, vol.55, pp.47-56, 2016.

E. A. Van-vliet, G. Forte, L. Holtman, J. C. Den-burger, A. Sinjewel et al., Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation, Epilepsia, vol.53, issue.7, pp.1254-1263, 2012.

A. Vezzani and T. Granata, Brain Inflammation in Epilepsy: Experimental and Clinical Evidence, Epilepsia, vol.46, issue.11, pp.1724-1743, 2005.

A. Vezzani, J. French, T. Bartfai, and T. Z. Baram, The role of inflammation in epilepsy, Nature Reviews Neurology, vol.7, issue.1, pp.31-40, 2010.

Z. Wang, Z. Chen, J. Yang, Z. Yang, J. Yin et al., Identification of two phosphorylation sites essential for annexin A1 in blood?brain barrier protection after experimental intracerebral hemorrhage in rats, Journal of Cerebral Blood Flow & Metabolism, vol.37, issue.7, pp.2509-2525, 2016.

Y. H. Yang, D. Aeberli, A. Dacumos, J. R. Xue, and E. F. Morand, Annexin-1 Regulates Macrophage IL-6 and TNF via Glucocorticoid-Induced Leucine Zipper, The Journal of Immunology, vol.183, issue.2, pp.1435-1445, 2009.

Y. H. Yang, M. L. Toh, C. D. Clyne, M. Leech, D. Aeberli et al., Annexin 1 Negatively Regulates IL-6 Expression via Effects on p38 MAPK and MAPK Phosphatase-1, The Journal of Immunology, vol.177, issue.11, pp.8148-8153, 2006.